S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
He Is Giving Away Bitcoin (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
He Is Giving Away Bitcoin (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
He Is Giving Away Bitcoin (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
He Is Giving Away Bitcoin (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:NTEC

Intec Pharma (NTEC) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free NTEC Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$9.15
▼
$36.20
52-Week Range
N/A
Volume
988,300 shs
Average Volume
543,436 shs
Market Capitalization
$8.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
NTEC stock logo

About Intec Pharma Stock (NASDAQ:NTEC)

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel.

NTEC Stock News Headlines

March 15, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Indaptus Therapeutics Amid Positive Clinical and Financial Outlook
March 7, 2024 | markets.businessinsider.com
Buy Rating Affirmed on Indaptus Therapeutics as Decoy20 Advances in Phase 1 with Promising Developments
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 18, 2024 | msn.com
Stocks to Watch Today: RVNL,Glenmark Pharma, PB Fintech,Sula Vineyards and more
February 2, 2024 | msn.com
Chhattisgarh education minister calls for expansion of central schools in the state
August 15, 2023 | markets.businessinsider.com
H.C. Wainwright Sticks to Its Buy Rating for Indaptus Therapeutics (INDP)
June 16, 2023 | finance.yahoo.com
NGENF - NervGen Pharma Corp.
May 12, 2023 | marketwatch.com
10-Q: INDAPTUS THERAPEUTICS, INC.
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
May 10, 2023 | marketwatch.com
Fibromyalgia Treatment Market Research | 2023-2030
May 9, 2023 | marketwatch.com
Early Pregnancy Test Kit Market May Set Epic Growth Story Major Players – Abbott, Church & Dwight, SPD Swiss Precision Diagnostics GmbH
May 4, 2023 | marketwatch.com
Fibromyalgia Treatment Market Share, Size, Financial Summaries Analysis from 2023 to 2028
April 28, 2023 | marketwatch.com
Fibromyalgia Treatment Market Share by 2031
April 24, 2023 | ca.finance.yahoo.com
Intec Pharma Ltd (5NU.SG)
March 30, 2023 | marketwatch.com
Fibromyalgia Treatment Market Size, Share, Outlook and Forecast to 2031
March 18, 2023 | markets.businessinsider.com
Maxim Group Reaffirms Their Buy Rating on Indaptus Therapeutics (INDP)
March 2, 2023 | marketwatch.com
Fibromyalgia Treatment Market Forecast: An Analysis of Industry Trends for 2023-2028
February 19, 2023 | marketwatch.com
Global Parkinson’s Disease Treatment Market Opportunities, Business Statistics Research Report 2030 By VMReports
February 15, 2023 | marketwatch.com
Fibromyalgia Treatment Market Size 2023 With Over-All Dominated, Share Of Everywhere, Ease Of Access Of Solutions
January 30, 2023 | marketwatch.com
Syphilis Rapid Test Kit Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2028
January 23, 2023 | marketwatch.com
Fibromyalgia Treatment Market Industry Updates, New Opportunities, Major Strategies, And Forecast 2028
December 29, 2022 | marketwatch.com
With 1.7% CAGR, Fibromyalgia Treatment Market 2023 Is Flourishing Around the World by 2028 | 116 Pages Report
December 21, 2022 | marketwatch.com
Fibromyalgia Treatment Market (New Report) to Witness A Pronounce Growth During 2023-2028 | 116 Pages Report
October 17, 2022 | marketwatch.com
Fibromyalgia Treatment Market Size in 2022 with Latest Report of 100 Pages & Business Forecast up to 2028 by Value Chain Analysis | No of Pages 100
August 28, 2022 | marketwatch.com
Fibromyalgia Treatment Market Size and Share 2022 Analysis Report by Industry Trends, Drivers, Applications, Sale and Forecast to 2028
July 5, 2022 | investing.com
World Holdings Co Ltd (2429)
June 4, 2022 | finanznachrichten.de
Beroe Inc.: Beroe partners with Mintec to power its intelligence offering with market-leading commodity price data
See More Headlines
Receive NTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intec Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/17/2021
Today
4/18/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NTEC
CUSIP
N/A
CIK
1638381
Web
www.intecpharma.com
Phone
(722) 586-4657
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($16.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,130,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-96.37%
Return on Assets
-68.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.34
Quick Ratio
2.34

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$16.18 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
898,000
Free Float
N/A
Market Cap
$8.65 million
Optionable
Optionable
Beta
0.83
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Jeffrey A. Meckler
    Vice Chairman & Chief Executive Officer
  • Nir Sassi
    President & Chief Financial Officer
  • Michael James Newman
    Director & Chief Scientific Officer
  • Anna Hotovely-Salomon
    Director-Clinical Affairs
  • Walt A. Linscott
    Chief Business Officer

Key Competitors

View All Competitors

NTEC Stock Analysis - Frequently Asked Questions

How were Intec Pharma's earnings last quarter?

Intec Pharma Ltd (NASDAQ:NTEC) posted its quarterly earnings data on Monday, May, 17th. The biotechnology company reported ($3.84) EPS for the quarter, missing analysts' consensus estimates of ($3.48) by $0.36.

When did Intec Pharma's stock split?

Shares of Intec Pharma reverse split on Tuesday, July 27th 2021. The 1-4 reverse split was announced on Tuesday, July 27th 2021. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, July 27th 2021. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of Intec Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intec Pharma investors own include SCYNEXIS (SCYX), Inovio Pharmaceuticals (INO), Dynavax Technologies (DVAX), Nabriva Therapeutics (NBRV), Onconova Therapeutics (ONTX), Viking Therapeutics (VKTX), Allena Pharmaceuticals (ALNA), T2 Biosystems (TTOO) and Acasti Pharma (ACST).

When did Intec Pharma IPO?

Intec Pharma (NTEC) raised $30 million in an IPO on Tuesday, August 4th 2015. The company issued 5,000,000 shares at $6.00 per share. Maxim Group and Roth Capital Partners acted as the underwriters for the IPO.

This page (NASDAQ:NTEC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company